Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:ARVR NASDAQ:EDUT NASDAQ:EKG NASDAQ:XDNA On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeARVRFirst Trust Indxx Metaverse ETF$54.57-5.7%$51.07$42.61▼$58.55$5.46M1.24342 shs1,257 shsEDUTGlobal X Education ETF$20.54$20.54$18.40▼$25.52$2.67M0.87477 shsN/AEKGFirst Trust Nasdaq Lux Digital Health Solutions ETF$17.31-1.9%$16.51$15.71▼$20.30$2.60M1.32699 shs483 shsXDNAKelly CRISPR & Gene Editing Technology ETF$7.38$7.38$5.87▼$11.83$2.21M0.923,034 shsN/A10 Stocks Set to Soar in 2026Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Summer 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceARVRFirst Trust Indxx Metaverse ETF0.00%-4.46%+1.15%+21.16%+25.99%EDUTGlobal X Education ETF0.00%0.00%0.00%0.00%0.00%EKGFirst Trust Nasdaq Lux Digital Health Solutions ETF0.00%+0.17%+4.06%+0.06%-0.12%XDNAKelly CRISPR & Gene Editing Technology ETF0.00%0.00%0.00%0.00%0.00%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeARVRFirst Trust Indxx Metaverse ETF$54.57-5.7%$51.07$42.61▼$58.55$5.46M1.24342 shs1,257 shsEDUTGlobal X Education ETF$20.54$20.54$18.40▼$25.52$2.67M0.87477 shsN/AEKGFirst Trust Nasdaq Lux Digital Health Solutions ETF$17.31-1.9%$16.51$15.71▼$20.30$2.60M1.32699 shs483 shsXDNAKelly CRISPR & Gene Editing Technology ETF$7.38$7.38$5.87▼$11.83$2.21M0.923,034 shsN/A10 Stocks Set to Soar in 2026Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Summer 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceARVRFirst Trust Indxx Metaverse ETF0.00%-4.46%+1.15%+21.16%+25.99%EDUTGlobal X Education ETF0.00%0.00%0.00%0.00%0.00%EKGFirst Trust Nasdaq Lux Digital Health Solutions ETF0.00%+0.17%+4.06%+0.06%-0.12%XDNAKelly CRISPR & Gene Editing Technology ETF0.00%0.00%0.00%0.00%0.00%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceARVRFirst Trust Indxx Metaverse ETF 2.62Moderate Buy$54.57N/AEDUTGlobal X Education ETF 2.40Hold$20.54N/AEKGFirst Trust Nasdaq Lux Digital Health Solutions ETF 2.69Moderate Buy$17.31N/AXDNAKelly CRISPR & Gene Editing Technology ETF 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookARVRFirst Trust Indxx Metaverse ETFN/AN/AN/AN/AN/AN/AEDUTGlobal X Education ETFN/AN/AN/AN/AN/AN/AEKGFirst Trust Nasdaq Lux Digital Health Solutions ETFN/AN/AN/AN/AN/AN/AXDNAKelly CRISPR & Gene Editing Technology ETFN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateARVRFirst Trust Indxx Metaverse ETFN/AN/A29.06N/AN/AN/AN/AN/AN/AEDUTGlobal X Education ETFN/AN/A27.61N/AN/AN/AN/AN/AN/AEKGFirst Trust Nasdaq Lux Digital Health Solutions ETFN/AN/A38.88N/AN/AN/AN/AN/AN/AXDNAKelly CRISPR & Gene Editing Technology ETFN/AN/A17.02N/AN/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthARVRFirst Trust Indxx Metaverse ETF$0.260.48%N/AN/AN/AEDUTGlobal X Education ETF$0.271.31%N/AN/AN/AEKGFirst Trust Nasdaq Lux Digital Health Solutions ETFN/AN/AN/AN/AN/AXDNAKelly CRISPR & Gene Editing Technology ETFN/A0.12%N/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipARVRFirst Trust Indxx Metaverse ETFN/AEDUTGlobal X Education ETFN/AEKGFirst Trust Nasdaq Lux Digital Health Solutions ETFN/AXDNAKelly CRISPR & Gene Editing Technology ETFN/AInsider OwnershipCompanyInsider OwnershipARVRFirst Trust Indxx Metaverse ETFN/AEDUTGlobal X Education ETFN/AEKGFirst Trust Nasdaq Lux Digital Health Solutions ETFN/AXDNAKelly CRISPR & Gene Editing Technology ETFN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableARVRFirst Trust Indxx Metaverse ETFN/A100,000N/AOptionableEDUTGlobal X Education ETF147,000130,000N/ANot OptionableEKGFirst Trust Nasdaq Lux Digital Health Solutions ETFN/A150,000N/AOptionableXDNAKelly CRISPR & Gene Editing Technology ETFN/A300,000N/AOptionableEDUT, EKG, ARVR, and XDNA HeadlinesRecent News About These CompaniesCathie Wood buys the dip in gene-editing firm CRISPR TherapeuticsMarch 11, 2026 | seekingalpha.comCRISPR unlocks a new way to defeat resistant lung cancerNovember 17, 2025 | sciencedaily.comSCRISPR breakthrough reverses chemotherapy resistance in lung cancerNovember 17, 2025 | msn.comCRISPR Therapeutics Reports Q3 2025 Financial ResultsNovember 12, 2025 | msn.comInvestment Guide to Genetics Stocks and ETFsAugust 28, 2025 | nai500.comNCHOP, Penn advance CRISPR gene editing with fast-developed treatment for an infant with a rare diseaseMay 15, 2025 | msn.comNobel Prize winners convince court to revive CRISPR patent disputeMay 12, 2025 | reuters.comBiotech investors: Stop expecting CRISPR science to make big leapsApril 14, 2025 | statnews.comSAI and gene editing promise ‘bespoke proteins’ for biotechOctober 8, 2024 | siliconrepublic.comSWeight loss drug breakthroughs, gene therapies, and more: 8 clinical trials to watch right nowOctober 2, 2024 | yahoo.comK-12 Genome Editing at Only $2 a PopSeptember 27, 2024 | yahoo.comVertex Stock: Came For CF Drugs, Staying For Gene TherapyAugust 2, 2024 | seekingalpha.comCRISPR can treat common form of inherited blindness, early data hintMay 15, 2024 | msn.comCRISPR gene editing: in summaryMarch 27, 2024 | biotechniques.comBCRISPR Technology Takes Center Stage at SXSW 2024 for the First TimeMarch 8, 2024 | markets.businessinsider.comIntellia Collaborates With ReCode To Develop Gene Therapy For Cystic FibrosisFebruary 15, 2024 | markets.businessinsider.comCRISPR Technology: Unveiling the Breakthrough in Gene Editing and Its Far-Reaching ImplicationsJanuary 18, 2024 | techbullion.comTHere's Why CRISPR Therapeutics Stock Rose 54% Last YearJanuary 15, 2024 | msn.comGene editing is now a medical realityDecember 8, 2023 | news.yahoo.comFDA approves first use of CRISPR gene editing to treat sickle cell diseaseDecember 8, 2023 | news.yahoo.comMedia Sentiment Over TimeEDUT, EKG, ARVR, and XDNA Company DescriptionsFirst Trust Indxx Metaverse ETF NASDAQ:ARVR$54.57 -3.27 (-5.65%) As of 06/5/2026 03:58 PM EasternThe First Trust Indxx Metaverse ETF (ARVR) is an exchange-traded fund that is based on the Indxx Metaverse index. The fund tracks a modified equal-weighted index of stocks, spanning a broad range of industries globally, that are involved in business activities associated with the Metaverse. ARVR was launched on Apr 19, 2022 and is managed by First Trust.Global X Education ETF NASDAQ:EDUT$20.54 0.00 (0.00%) As of 06/5/2026The Global X Education ETF (EDUT) is an exchange-traded fund that is based on the Indxx Global Education Thematic index, a market-cap-weighted index of global companies providing products and services that facilitate education. EDUT was launched on Jul 10, 2020 and is managed by Global X.First Trust Nasdaq Lux Digital Health Solutions ETF NASDAQ:EKG$17.31 -0.33 (-1.87%) As of 06/5/2026 02:40 PM EasternThe First Trust Nasdaq Lux Digital Health Solutions ETF (EKG) is an exchange-traded fund that is based on the NASDAQ Lux Health Tech index. The fund tracks a market cap-weighted index of globally-listed companies engaged in digital health technologies. EKG was launched on Mar 22, 2022 and is managed by First Trust.Kelly CRISPR & Gene Editing Technology ETF NASDAQ:XDNA$7.38 0.00 (0.00%) As of 06/5/2026The Strategic CRISPR & Gene Editing Technology ETF (XDNA) is an exchange-traded fund that mostly invests in health care equity. The fund tracks a market-cap-weighted index of companies in developed markets that focus on the advancements in DNA modification technology. XDNA was launched on Jan 12, 2022 and is managed by Kelly. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 06/01 - 06/05 Samsara Just Answered The AI Question—Is Wall Street Ready To Listen? A Lulu of a Miss Sends Lululemon to New Lows—Look Out Below Five Below Down 12% Post Earnings—Is the Selloff Overdone? Petco Faces Tough Competition, But Momentum Is Building IREN's 800MW Bet Flips the AI Power Switch Buy the Dip? Broadcom's AI Moat Is Wider Than Ever CrowdStrike Earnings Beat Sparks Selloff—Buy the Dip? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
